Np mrd loader

Record Information
Version2.0
Created at2024-03-14 02:45:09 UTC
Updated at2024-11-01 01:39:05 UTC
NP-MRD IDNP0332621
Natural Product DOIhttps://doi.org/10.57994/1881
Secondary Accession NumbersNone
Natural Product Identification
Common NamePepticinnamin E
DescriptionPepticinnamin E belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Pepticinnamin E was first documented in 2009 (PMID: 19894725). Based on a literature review a small amount of articles have been published on Pepticinnamin E (PMID: 24059235) (PMID: 32489098) (PMID: 30694017) (PMID: 19890497).
Structure
Thumb
Synonyms
ValueSource
Pepticinnamine eMeSH
Chemical FormulaC49H54ClN5O10
Average Mass908.4500 Da
Monoisotopic Mass907.35592 Da
IUPAC Name[(2R)-3,6-dioxopiperazin-2-yl]methyl (2S)-2-[(2S)-3-(2-chloro-3-hydroxy-4-methoxyphenyl)-2-[(2R)-3-(4-hydroxyphenyl)-N-methyl-2-[(2E)-3-{2-[(1Z)-pent-1-en-1-yl]phenyl}prop-2-enamido]propanamido]-N-methylpropanamido]-3-phenylpropanoate
Traditional Name[(2R)-3,6-dioxopiperazin-2-yl]methyl (2S)-2-[(2S)-3-(2-chloro-3-hydroxy-4-methoxyphenyl)-2-[(2R)-3-(4-hydroxyphenyl)-N-methyl-2-[(2E)-3-{2-[(1Z)-pent-1-en-1-yl]phenyl}prop-2-enamido]propanamido]-N-methylpropanamido]-3-phenylpropanoate
CAS Registry NumberNot Available
SMILES
CCC\C=C/C1=CC=CC=C1\C=C\C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N(C)[C@@H](CC1=CC=C(OC)C(O)=C1Cl)C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)OC[C@H]1NC(=O)CNC1=O
InChI Identifier
InChI=1S/C49H54ClN5O10/c1-5-6-8-15-33-16-11-12-17-34(33)21-25-42(57)52-37(26-32-18-22-36(56)23-19-32)47(61)54(2)39(28-35-20-24-41(64-4)45(59)44(35)50)48(62)55(3)40(27-31-13-9-7-10-14-31)49(63)65-30-38-46(60)51-29-43(58)53-38/h7-25,37-40,56,59H,5-6,26-30H2,1-4H3,(H,51,60)(H,52,57)(H,53,58)/b15-8-,25-21+/t37-,38-,39+,40+/m1/s1
InChI KeyFAVCPKLIWNVVMG-AGJVLQOFSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
mirabilis P8-A2
      Not Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentPeptides
Alternative Parents
Substituents
  • Alpha peptide
  • Tyrosine or derivatives
  • Phenylalanine or derivatives
  • Alpha-amino acid ester
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Cinnamic acid amide
  • Cinnamic acid or derivatives
  • Alpha-amino acid or derivatives
  • Amphetamine or derivatives
  • Methoxyphenol
  • Phenoxy compound
  • Anisole
  • Dioxopiperazine
  • 2-halophenol
  • 2-chlorophenol
  • Methoxybenzene
  • Phenol ether
  • Styrene
  • 2,5-dioxopiperazine
  • Phenol
  • Chlorobenzene
  • Alkyl aryl ether
  • Fatty acid ester
  • Halobenzene
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Fatty acyl
  • Aryl halide
  • Benzenoid
  • Aryl chloride
  • Piperazine
  • Monocyclic benzene moiety
  • 1,4-diazinane
  • Tertiary carboxylic acid amide
  • Secondary carboxylic acid amide
  • Lactam
  • Carboxylic acid ester
  • Carboxamide group
  • Ether
  • Azacycle
  • Monocarboxylic acid or derivatives
  • Organoheterocyclic compound
  • Organooxygen compound
  • Carbonyl group
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP5.77ChemAxon
pKa (Strongest Acidic)8.42ChemAxon
pKa (Strongest Basic)-0.67ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area203.91 ŲChemAxon
Rotatable Bond Count21ChemAxon
Refractivity246.55 m³·mol⁻¹ChemAxon
Polarizability93.71 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8685394
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound10509993
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Moorthy NS, Sousa SF, Ramos MJ, Fernandes PA: Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis. Curr Med Chem. 2013;20(38):4888-923. doi: 10.2174/09298673113206660262. [PubMed:24059235 ]
  2. Ge Y, Wang G, Jin J, Liu T, Ma X, Zhang Z, Geng T, Song J, Ma X, Zhang Y, Yang D, Ma M: Discovery and Biosynthesis of Pepticinnamins G-M Featuring Three Enzymes-Catalyzed Nonproteinogenic Amino Acid Formation. J Org Chem. 2020 Jul 2;85(13):8673-8682. doi: 10.1021/acs.joc.0c01113. Epub 2020 Jun 16. [PubMed:32489098 ]
  3. Santa Maria KC, Chan AN, O'Neill EM, Li B: Targeted Rediscovery and Biosynthesis of the Farnesyl-Transferase Inhibitor Pepticinnamin E. Chembiochem. 2019 Jun 3;20(11):1387-1393. doi: 10.1002/cbic.201900025. Epub 2019 May 2. [PubMed:30694017 ]
  4. Tan KT, Guiu-Rozas E, Bon RS, Guo Z, Delon C, Wetzel S, Arndt S, Alexandrov K, Waldmann H, Goody RS, Wu YW, Blankenfeldt W: Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors. J Med Chem. 2009 Dec 24;52(24):8025-37. doi: 10.1021/jm901117d. [PubMed:19894725 ]
  5. Xu GG, Etzkorn FA: Pin1 as an anticancer drug target. Drug News Perspect. 2009 Sep;22(7):399-407. doi: 10.1358/dnp.2009.22.7.1381751. [PubMed:19890497 ]